Skip to main content

Erste Asset Management GmbH

Source: SEC Form 13F · as of Mar 2026

Erste Asset Management GmbH holds 48 biotech & pharma companies tracked by BioSniper, totaling $344.7M in value as of Mar 2026 (SEC Form 13F).

Companies held

48

Total value held

$344.7M

BioSniper AIPage evidence connected

Prepared research question

What matters most for AGIOS PHARMACEUTICALS, INC. (AGIO)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
AGIOAGIOS PHARMACEUTICALS, INC.2,704,900$80.1M
GILDGILEAD SCIENCES, INC.547,833$74.8M
REGNREGENERON PHARMACEUTICALS, INC.57,209$42.9M
STOKStoke Therapeutics, Inc.446,000$14.2M
BBIOBridgeBio Pharma, Inc.189,725$13.2M
ALNYALNYLAM PHARMACEUTICALS, INC.36,310$11.5M
DNAGinkgo Bioworks Holdings Inc.1,947,728$10.7M
ARGXARGENX SE14,206$10.0M
INSMINSMED Inc41,603$6.4M
ONCBeOne Medicines Ltd.21,900$6.2M
ROIVRoivant Sciences Ltd.214,000$5.7M
BHVNBiohaven Ltd.693,300$5.6M
RVMDREVOLUTION MEDICINES, INC.59,400$5.5M
IONSIONIS PHARMACEUTICALS INC71,800$5.2M
ABVXAbivax SA50,000$5.1M
CYTKCYTOKINETICS INC76,950$4.8M
VYGRVoyager Therapeutics, Inc.1,095,141$4.2M
ARWRARROWHEAD PHARMACEUTICALS, INC.73,000$4.2M
IMVTImmunovant, Inc.144,500$3.4M
INCYIncyte Corp.34,200$3.1M
ACADACADIA PHARMACEUTICALS INC133,700$2.8M
EXELEXELIXIS, INC.52,500$2.2M
BMRNBIOMARIN PHARMACEUTICAL INC38,520$2.1M
TERNTerns Pharmaceuticals, Inc.37,000$2.0M
APGEApogee Therapeutics, Inc.24,000$1.9M
NKTRNEKTAR THERAPEUTICS28,000$1.8M
AXSMAxsome Therapeutics, Inc.11,000$1.8M
ARQTArcutis Biotherapeutics, Inc.73,100$1.6M
VKTXViking Therapeutics, Inc.47,000$1.4M
PTGXProtagonist Therapeutics, Inc13,500$1.3M
RNACCartesian Therapeutics, Inc.221,705$1.3M
NUVLNuvalent, Inc.11,500$1.1M
FOLDAMICUS THERAPEUTICS, INC.63,850$921K
LGNDLigand Pharmaceuticals Incorporated4,300$828K
OCULOCULAR THERAPEUTIX, INC110,000$814K
SRRKScholar Rock Holding Corp18,600$801K
SLNOSOLENO THERAPEUTICS INC25,600$779K
OLMAOlema Pharmaceuticals, Inc.38,000$510K
DNLIDenali Therapeutics Inc.26,900$486K
ADPTAdaptive Biotechnologies Corp35,700$459K
APLSApellis Pharmaceuticals, Inc.25,300$432K
AUTLAutolus Therapeutics plc195,000$248K
ABCLAbCellera Biologics Inc.62,000$203K
RGNXREGENXBIO Inc.13,000$101K
BCYCBICYCLE THERAPEUTICS PLC14,000$61K
RNAAtrium Therapeutics Inc.3,600$49K
OGNOrganon & Co.0$0
RDYDR REDDYS LABORATORIES LTD0$0

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.